ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEVEN GOLDSTEIN MD

Internal Medicine

19,692

$2.33M

704
445 are 65+

14%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $61

JAMES FELTT M.D.

Internal Medicine

19,677

$915K

543
411 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

BALA RANGASWAMI MD

Internal Medicine

19,445

$1.3M

811
575 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $61

MICHAEL ISRAEL M.D.

Internal Medicine

19,321

$1.13M

598
416 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

KAMRAN SIDDIQUI M.D.

Internal Medicine

19,165

$1.02M

671
475 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

DIVYESH PUROHIT MD

Internal Medicine

19,107

$1.27M

686
461 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $61

SHIV KAPOOR M.D.

Internal Medicine

19,088

$839K

437
364 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $61

PRIYA KUMAR MD

Internal Medicine

19,018

$1M

683
546 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

JEFFREY DUVALL

Internal Medicine

19,003

$843K

599
449 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $61

BRADFORD BOMBA MD

Internal Medicine

18,843

$1.27M

850
747 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $61

MARY ROBERTSON MD

Internal Medicine

18,834

$940K

648
581 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

LLOYD TROMMLER M.D.

Internal Medicine

18,829

$1.07M

840
680 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

KEVIN SCHENDEL MD

Internal Medicine

18,527

$891K

616
507 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $61

ROBERT SUER M.D.

Internal Medicine

18,416

$1.17M

617
564 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

ASRAR SHEIKH M.D.

Internal Medicine

18,202

$815K

400
307 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

JOSEPH BEAVEN M.D.

Internal Medicine

18,161

$1.41M

660
383 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $61

KAMAL GIRGIS MD

Internal Medicine

17,980

$1.04M

606
460 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

27%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

ROBERT ANDERSON MD

Internal Medicine

17,589

$1.26M

541
392 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $61

ANTWAN MARDINI MD

Internal Medicine

17,581

$887K

580
454 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

STEVEN KINSEY MD

Internal Medicine

17,547

$1.03M

721
654 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

GORDON VOGEL MD

Internal Medicine

17,541

$1.14M

725
596 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $61

PANKAJ KUMAR MD

Internal Medicine

17,331

$768K

567
509 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $61

VUPPALA REDDY M.D.

Internal Medicine

17,135

$1.04M

756
673 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

REYNALDO CARANDANG M.D.

Internal Medicine

17,126

$772K

462
374 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

ROBERT CHUA M.D.

Internal Medicine

17,102

$1.1M

331
154 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

45%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank